American Journal of Hematology
Published by John Wiley & Sons
ISSN : 0361-8609 eISSN : 1096-8652
Abbreviation : Am. J. Hematol.
Aims & Scope
The American Journal of Hematology provides broad coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease.
The journal publishes original contributions in non-malignant and malignant hematological diseases including clinical and basic studies in hemostasis and thrombosis, immunology, blood banking, and stem cell biology.
Clinical translational reports describing novel therapeutic approaches to diagnosis and treatment of hematological diseases are welcomed and encouraged.
The journal includes regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, letters and correspondence.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 9.9 |
2024 | 10.10 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 3.076 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
Journal Rank
Year | Value |
---|---|
2024 | 680 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 5151 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Hematological findings and complications of <scp>COVID</scp>â€19
Citation: 1360
Authors: Evangelos, Ioannis, Ismail, Efstathios, Theodoros N., Marianna, Theodora, Grigoris, Meletios A.
-
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
Citation: 1163
Authors: Morie A., Ray, Rodney H., Jean Paul, Bouke P., Philip N., Giampaolo, Philippe, Pierre, Vaishali, Orhan, Alan, Giles
-
Multiple myeloma: 2020 update on diagnosis, riskâ€stratification and management
Citation: 611
Authors: S. Vincent
-
Multiple myeloma: 2022 update on diagnosis, risk stratification, and management
Citation: 559
Authors: S. Vincent
-
An introduction to chimeric antigen receptor (CAR) Tâ€cell immunotherapy for human cancer
Citation: 467
Authors: Steven, Weimin, Erik F., Michael C., Joseph A.
-
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment
Citation: 407
Authors: Michael
-
Final analysis from RESONATE: Up to six years of followâ€up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
Citation: 397
Authors: Talha, Jennifer R., Susan, Jacqueline C., Paul M., Nishitha M., Steven, Constantine S., Stephen P., Ulrich, Thomas J., Carol, Marco, Jan A., John C., Peter, Sandra, Anita, James P., Jennifer A.
-
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
Citation: 386
Authors: Maria Domenica, Josep, Angel, Axel, Wolfram, Carolyn S., Iain C., Gerhard, Clara, Rezan, Nicholas J., Donat R., Ali T., Khaled M.